BioSystics Inc.

Uncategorized

BioSystics, Inc., a database and analytics company, announced that it has merged with Nortis, a microphysiology systems platform company, to form Numa Biosciences, Inc., a precision medicine platform company

PITTSBURGH, June 26, 2023 /PRNewswire/ — BioSystics, Inc., a recent spin-off from the University of Pittsburgh (UPitt), has been developing the Microphysiology Systems Database, the core of the BioSystics Analytics Platform (BioSystics-AP™), with funding over the last ten years from … Read More

Visit BioSystics at the MPS World Summit 2023!

BioSystics is proud to again sponsor the MPS World Summit in its second year. The MPS World Summit 2023 will be held June 26-June 30, 2023 in Berlin, Germany. Visit us at Booth #52!

BioSystics is proud to be a sponsor of the MPS World Summit in 2023

BioSystics is proud to be a sponsor of the 2nd Microphysiological Systems World Summit being held in Berlin, June 26 – June 30, 2023.  Visit us at our booth to learn how the BioSystics-Analytics Platform™ is being used by pharma and … Read More

BioSystics can help you comply with the new NIH Data Management and Sharing Policy

BioSystics Analytics Platform™ is recognized as a domain-specific data repository by the NIH. In addition to its powerful analytic capabilities, BioSystics-AP™ can help you comply with the new NIH Policy for Data Management and Sharing. Contact us for information to … Read More

BioSystics, Inc. is planning Series A financing

(May 4, 2022) BioSystics, Inc., the company “accelerating the path to patient digital twins”, is seeking seed funding of up to $1.5M to hire senior management and to add to the technical staff for commercial growth after ten years of … Read More

BioSystics, Inc., a recent spin-off from the University of Pittsburgh is seeking Series A financing to accelerate the path to patient digital twins for the pharmaceutical and healthcare industries.

BioSystics, Inc., a recent spin-off from the University of Pittsburgh is seeking Series A financing to accelerate the path to patient digital twins for the pharmaceutical and healthcare industries. The BioSystics Analytics Platform™ (BioSystics-AP™) captures, analyzes, computationally models and shares … Read More

Hello from BioSystics!

Board Chairman Lans Taylor announced that BioSystics, Inc was incorporated on September 14, 2021 to commercialize the MPS Database. BioSystics will take over from the MPS Database Center the management and hosting of the current version of the MPS Database … Read More

BioSystics is to be a Silver sponsor of the MPS World Summit in 2022

BioSystics is proud to be a Silver sponsor of the MPS World Summit being held in New Orleans, May 31 – June 3, 2022.  At the meeting, we will be presenting the BioSystics Analytics platform, a platform for accessing, managing, … Read More

Funding from NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM)…

CEO Mark Schurdak announced that NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) has provided funding to implement an iPSC portal to promote sharing of iPSCs among the MPSCoRe COVID-19 consortium members. Access to the portal will … Read More

Joint publication with Tissue Chip Validation Consortium at Texas A&M University (TAMU)

The MPS Database Center has jointly published a paper with the Tissuce Chip Validation Center at Texas A&M University (TAMU) that demonstrates the use of the MPS-Db for the analysis and reproducibility of the microphysiologyical systems. Sakolish C, Reese CE, … Read More